Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-cash Items (2018 - 2025)

TransMedics has reported Non-cash Items over the past 8 years, most recently at $1.9 million for Q4 2025.

  • Quarterly results put Non-cash Items at $1.9 million for Q4 2025, down 97.48% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 97.48% YoY), and the annual figure for FY2025 was $1.9 million, down 97.48%.
  • Non-cash Items for Q4 2025 was $1.9 million at TransMedics, down from $76.9 million in the prior quarter.
  • Over the last five years, Non-cash Items for TMDX hit a ceiling of $159.3 million in Q4 2023 and a floor of $1.9 million in Q4 2025.
  • Median Non-cash Items over the past 5 years was $76.9 million (2024), compared with a mean of $77.0 million.
  • Biggest five-year swings in Non-cash Items: surged 803.08% in 2022 and later tumbled 97.48% in 2025.
  • TransMedics' Non-cash Items stood at $14.6 million in 2021, then surged by 803.08% to $132.1 million in 2022, then rose by 20.64% to $159.3 million in 2023, then tumbled by 51.77% to $76.9 million in 2024, then tumbled by 97.48% to $1.9 million in 2025.
  • The last three reported values for Non-cash Items were $1.9 million (Q4 2025), $76.9 million (Q4 2024), and $159.3 million (Q4 2023) per Business Quant data.